Genmab’s 25th Anniversary

From Where We Started to Where We are Going​

February 25 marks Genmab’s 25th anniversary. Over the past quarter-century, Genmab has emerged as a scientific leader in antibody research

Learn more

Investors

Annual Report 2023

On February 14, Genmab announced its full year 2023 financial results.

See highlights and listen to webcast

Investors

Annual General Meeting 2024

Genmab A/S’ Annual General Meeting 2024 will take place on March 13, 2024.

Learn more and register

From Where We Started to Where We are Going​

Annual Report 2023

Annual General Meeting 2024

Load more

On the lookout for a life-changing career?

Join our team of extra[not]ordinary™ people and become part of a company working to pioneer antibody medicines for cancer and other serious diseases. 
 

Explore your career opportunities

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.